List of SBIR/STTR awards granted to AVANT IMMUNOTHERAPEUTICS, INC.

List of SBIR/STTR awards granted to AVANT IMMUNOTHERAPEUTICS, INC.

List of SBIR/STTR awards granted to ECHO TECHNOLOGIES, INC.

List of SBIR/STTR awards granted to Cairn Biosciences

List of SBIR/STTR awards granted to MICROWAVE TECHNOLGIES, INC.

List of AxoGen patents

List of Pacific Biosciences patents

where

SBIR/STTR Award Recipient

is

‌

AVANT IMMUNOTHERAPEUTICS, INC.

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase II Award, September 2020	A SBIR Phase II contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. in September, 2020 for $1,204,513.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ AVANT IMMUNOTHERAPEUTICS, INC.		National Institutes of Health	SBIR	2R44CA192435-04A1	Phase II	1,204,513	September 3, 2020	sbir.gov/node/1910839
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase II Award, September 2015	A SBIR Phase II contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. in September, 2015 for $1,620,622.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR	2R44CA192435-02	Phase II	1,620,622	September 1, 2015	sbir.gov/node/1057805
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase II Award, June 2014	A SBIR Phase II contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. in June, 2014 for $1,988,027.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR	2R44AI095159-02A1	Phase II	1,988,027	June 15, 2014	sbir.gov/node/1031579
	‌ Celldex Therapeutics, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $199,398.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR	N43CO120074	Phase I	199,398		sbir.gov/node/402299
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $120,511.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR	1R43AI053021-01	Phase I	120,511		sbir.gov/content/live-attenuated-bacterial-vaccines-against-anthrax-0
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $130,810.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR	1R43AI065039-01	Phase I	130,810		sbir.gov/content/live-attenuated-salmonella-vaccine-against-campylobacter-0
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $126,861.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR	1R43AI053910-01	Phase I	126,861		sbir.gov/content/feasibility-evaluation-oral-typhoid-fever-vaccine-0
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $750,000.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR	2R44AI053910-02	Phase II	750,000		sbir.gov/content/development-and-cgmp-manufacture-vitrified-typhoid-vaccine-0
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $218,442.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR		Phase I	218,442		sbir.gov/content/not-available-1658
	‌ AVANT IMMUNOTHERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $103,263.0 USD from the U.S. Department of Health & Human Services.	‌ AVANT IMMUNOTHERAPEUTICS, INC.			SBIR		Phase I	103,263		sbir.gov/content/not-available-1660

10 results

0 selected

10 results

0 selected